🔎 Trials Near Me

Hjem › Myelogen leukemi i kronisk fase › Washington

Kliniske studier for Myelogen leukemi i kronisk fase i Washington

3 studier for Myelogen leukemi i kronisk fase søker deltakere på steder i Washington.

Byer i Washington

Offisiell studietekst (engelsk)

Study of Olverembatinib (HQP1351) in Patients With CML-CP

  • Ascentage Investigative Site #1136, Edmonds
  • Ascentage Investigative Site #1135, Issaquah
  • Ascentage Investigative Site #1806, Seattle
  • og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06423911

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

  • Fred Hutchinson Cancer Research Center, Seattle
  • MultiCare Health System Institute, Tacoma
  • Northwest Medical Specialties, Tacoma
RekruttererObservasjonsstudie
Alder 18 til 100 · Alle kjønn · Oppdatert 20. jul. 2026 · NCT07091019

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

  • Fred Hutchinson Cancer Center, Seattle
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jan. 2026 · NCT06163430

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.